Global Pharmaceutical Cannabis Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pharmaceutical Cannabis Industry Forecast” looks at past sales and reviews total world Pharmaceutical Cannabis sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Cannabis sales for 2023 through 2029. With Pharmaceutical Cannabis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Cannabis industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Cannabis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Cannabis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pharmaceutical Cannabis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Cannabis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Cannabis.
The global Pharmaceutical Cannabis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceutical Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Cannabis players cover Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc., MedReleaf Corporation, Insys Therapeutics, Inc., CanniMed Therapeutics, Inc., Cara Therapeutics, Inc. and United Cannabis Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Cannabis market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pharmaceutical Cannabis market?
What factors are driving Pharmaceutical Cannabis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Cannabis market opportunities vary by end market size?
How does Pharmaceutical Cannabis break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Pharmaceutical Cannabis Industry Forecast” looks at past sales and reviews total world Pharmaceutical Cannabis sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Cannabis sales for 2023 through 2029. With Pharmaceutical Cannabis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Cannabis industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Cannabis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Cannabis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pharmaceutical Cannabis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Cannabis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Cannabis.
The global Pharmaceutical Cannabis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceutical Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Cannabis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Cannabis players cover Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc., MedReleaf Corporation, Insys Therapeutics, Inc., CanniMed Therapeutics, Inc., Cara Therapeutics, Inc. and United Cannabis Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Cannabis market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- THC-dominant
- CBD-dominant
- Balanced THC & CBD
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Canopy Growth Corporation
- GW Pharmaceuticals, plc
- Aurora Cannabis, Inc.
- Aphria, Inc.
- MedReleaf Corporation
- Insys Therapeutics, Inc.
- CanniMed Therapeutics, Inc.
- Cara Therapeutics, Inc.
- United Cannabis Corporation
What is the 10-year outlook for the global Pharmaceutical Cannabis market?
What factors are driving Pharmaceutical Cannabis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Cannabis market opportunities vary by end market size?
How does Pharmaceutical Cannabis break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Cannabis Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pharmaceutical Cannabis by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pharmaceutical Cannabis by Country/Region, 2018, 2022 & 2029
2.2 Pharmaceutical Cannabis Segment by Type
2.2.1 THC-dominant
2.2.2 CBD-dominant
2.2.3 Balanced THC & CBD
2.3 Pharmaceutical Cannabis Sales by Type
2.3.1 Global Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
2.3.2 Global Pharmaceutical Cannabis Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pharmaceutical Cannabis Sale Price by Type (2018-2023)
2.4 Pharmaceutical Cannabis Segment by Application
2.4.1 Cancer
2.4.2 Arthritis
2.4.3 Migraine
2.4.4 Epilepsy
2.4.5 Others
2.5 Pharmaceutical Cannabis Sales by Application
2.5.1 Global Pharmaceutical Cannabis Sale Market Share by Application (2018-2023)
2.5.2 Global Pharmaceutical Cannabis Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pharmaceutical Cannabis Sale Price by Application (2018-2023)
3 GLOBAL PHARMACEUTICAL CANNABIS BY COMPANY
3.1 Global Pharmaceutical Cannabis Breakdown Data by Company
3.1.1 Global Pharmaceutical Cannabis Annual Sales by Company (2018-2023)
3.1.2 Global Pharmaceutical Cannabis Sales Market Share by Company (2018-2023)
3.2 Global Pharmaceutical Cannabis Annual Revenue by Company (2018-2023)
3.2.1 Global Pharmaceutical Cannabis Revenue by Company (2018-2023)
3.2.2 Global Pharmaceutical Cannabis Revenue Market Share by Company (2018-2023)
3.3 Global Pharmaceutical Cannabis Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Cannabis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Cannabis Product Location Distribution
3.4.2 Players Pharmaceutical Cannabis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL CANNABIS BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Cannabis Market Size by Geographic Region (2018-2023)
4.1.1 Global Pharmaceutical Cannabis Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pharmaceutical Cannabis Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pharmaceutical Cannabis Market Size by Country/Region (2018-2023)
4.2.1 Global Pharmaceutical Cannabis Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pharmaceutical Cannabis Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pharmaceutical Cannabis Sales Growth
4.4 APAC Pharmaceutical Cannabis Sales Growth
4.5 Europe Pharmaceutical Cannabis Sales Growth
4.6 Middle East & Africa Pharmaceutical Cannabis Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Cannabis Sales by Country
5.1.1 Americas Pharmaceutical Cannabis Sales by Country (2018-2023)
5.1.2 Americas Pharmaceutical Cannabis Revenue by Country (2018-2023)
5.2 Americas Pharmaceutical Cannabis Sales by Type
5.3 Americas Pharmaceutical Cannabis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Cannabis Sales by Region
6.1.1 APAC Pharmaceutical Cannabis Sales by Region (2018-2023)
6.1.2 APAC Pharmaceutical Cannabis Revenue by Region (2018-2023)
6.2 APAC Pharmaceutical Cannabis Sales by Type
6.3 APAC Pharmaceutical Cannabis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Cannabis by Country
7.1.1 Europe Pharmaceutical Cannabis Sales by Country (2018-2023)
7.1.2 Europe Pharmaceutical Cannabis Revenue by Country (2018-2023)
7.2 Europe Pharmaceutical Cannabis Sales by Type
7.3 Europe Pharmaceutical Cannabis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Cannabis by Country
8.1.1 Middle East & Africa Pharmaceutical Cannabis Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pharmaceutical Cannabis Revenue by Country (2018-2023)
8.2 Middle East & Africa Pharmaceutical Cannabis Sales by Type
8.3 Middle East & Africa Pharmaceutical Cannabis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Cannabis
10.3 Manufacturing Process Analysis of Pharmaceutical Cannabis
10.4 Industry Chain Structure of Pharmaceutical Cannabis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Cannabis Distributors
11.3 Pharmaceutical Cannabis Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL CANNABIS BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Cannabis Market Size Forecast by Region
12.1.1 Global Pharmaceutical Cannabis Forecast by Region (2024-2029)
12.1.2 Global Pharmaceutical Cannabis Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Cannabis Forecast by Type
12.7 Global Pharmaceutical Cannabis Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Canopy Growth Corporation
13.1.1 Canopy Growth Corporation Company Information
13.1.2 Canopy Growth Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
13.1.3 Canopy Growth Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Canopy Growth Corporation Main Business Overview
13.1.5 Canopy Growth Corporation Latest Developments
13.2 GW Pharmaceuticals, plc
13.2.1 GW Pharmaceuticals, plc Company Information
13.2.2 GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Portfolios and Specifications
13.2.3 GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GW Pharmaceuticals, plc Main Business Overview
13.2.5 GW Pharmaceuticals, plc Latest Developments
13.3 Aurora Cannabis, Inc.
13.3.1 Aurora Cannabis, Inc. Company Information
13.3.2 Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.3.3 Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aurora Cannabis, Inc. Main Business Overview
13.3.5 Aurora Cannabis, Inc. Latest Developments
13.4 Aphria, Inc.
13.4.1 Aphria, Inc. Company Information
13.4.2 Aphria, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.4.3 Aphria, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aphria, Inc. Main Business Overview
13.4.5 Aphria, Inc. Latest Developments
13.5 MedReleaf Corporation
13.5.1 MedReleaf Corporation Company Information
13.5.2 MedReleaf Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
13.5.3 MedReleaf Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MedReleaf Corporation Main Business Overview
13.5.5 MedReleaf Corporation Latest Developments
13.6 Insys Therapeutics, Inc.
13.6.1 Insys Therapeutics, Inc. Company Information
13.6.2 Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.6.3 Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Insys Therapeutics, Inc. Main Business Overview
13.6.5 Insys Therapeutics, Inc. Latest Developments
13.7 CanniMed Therapeutics, Inc.
13.7.1 CanniMed Therapeutics, Inc. Company Information
13.7.2 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.7.3 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CanniMed Therapeutics, Inc. Main Business Overview
13.7.5 CanniMed Therapeutics, Inc. Latest Developments
13.8 Cara Therapeutics, Inc.
13.8.1 Cara Therapeutics, Inc. Company Information
13.8.2 Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.8.3 Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cara Therapeutics, Inc. Main Business Overview
13.8.5 Cara Therapeutics, Inc. Latest Developments
13.9 United Cannabis Corporation
13.9.1 United Cannabis Corporation Company Information
13.9.2 United Cannabis Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
13.9.3 United Cannabis Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 United Cannabis Corporation Main Business Overview
13.9.5 United Cannabis Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Cannabis Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pharmaceutical Cannabis by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pharmaceutical Cannabis by Country/Region, 2018, 2022 & 2029
2.2 Pharmaceutical Cannabis Segment by Type
2.2.1 THC-dominant
2.2.2 CBD-dominant
2.2.3 Balanced THC & CBD
2.3 Pharmaceutical Cannabis Sales by Type
2.3.1 Global Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
2.3.2 Global Pharmaceutical Cannabis Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pharmaceutical Cannabis Sale Price by Type (2018-2023)
2.4 Pharmaceutical Cannabis Segment by Application
2.4.1 Cancer
2.4.2 Arthritis
2.4.3 Migraine
2.4.4 Epilepsy
2.4.5 Others
2.5 Pharmaceutical Cannabis Sales by Application
2.5.1 Global Pharmaceutical Cannabis Sale Market Share by Application (2018-2023)
2.5.2 Global Pharmaceutical Cannabis Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pharmaceutical Cannabis Sale Price by Application (2018-2023)
3 GLOBAL PHARMACEUTICAL CANNABIS BY COMPANY
3.1 Global Pharmaceutical Cannabis Breakdown Data by Company
3.1.1 Global Pharmaceutical Cannabis Annual Sales by Company (2018-2023)
3.1.2 Global Pharmaceutical Cannabis Sales Market Share by Company (2018-2023)
3.2 Global Pharmaceutical Cannabis Annual Revenue by Company (2018-2023)
3.2.1 Global Pharmaceutical Cannabis Revenue by Company (2018-2023)
3.2.2 Global Pharmaceutical Cannabis Revenue Market Share by Company (2018-2023)
3.3 Global Pharmaceutical Cannabis Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Cannabis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Cannabis Product Location Distribution
3.4.2 Players Pharmaceutical Cannabis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL CANNABIS BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Cannabis Market Size by Geographic Region (2018-2023)
4.1.1 Global Pharmaceutical Cannabis Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pharmaceutical Cannabis Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pharmaceutical Cannabis Market Size by Country/Region (2018-2023)
4.2.1 Global Pharmaceutical Cannabis Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pharmaceutical Cannabis Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pharmaceutical Cannabis Sales Growth
4.4 APAC Pharmaceutical Cannabis Sales Growth
4.5 Europe Pharmaceutical Cannabis Sales Growth
4.6 Middle East & Africa Pharmaceutical Cannabis Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Cannabis Sales by Country
5.1.1 Americas Pharmaceutical Cannabis Sales by Country (2018-2023)
5.1.2 Americas Pharmaceutical Cannabis Revenue by Country (2018-2023)
5.2 Americas Pharmaceutical Cannabis Sales by Type
5.3 Americas Pharmaceutical Cannabis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Cannabis Sales by Region
6.1.1 APAC Pharmaceutical Cannabis Sales by Region (2018-2023)
6.1.2 APAC Pharmaceutical Cannabis Revenue by Region (2018-2023)
6.2 APAC Pharmaceutical Cannabis Sales by Type
6.3 APAC Pharmaceutical Cannabis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Cannabis by Country
7.1.1 Europe Pharmaceutical Cannabis Sales by Country (2018-2023)
7.1.2 Europe Pharmaceutical Cannabis Revenue by Country (2018-2023)
7.2 Europe Pharmaceutical Cannabis Sales by Type
7.3 Europe Pharmaceutical Cannabis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Cannabis by Country
8.1.1 Middle East & Africa Pharmaceutical Cannabis Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pharmaceutical Cannabis Revenue by Country (2018-2023)
8.2 Middle East & Africa Pharmaceutical Cannabis Sales by Type
8.3 Middle East & Africa Pharmaceutical Cannabis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Cannabis
10.3 Manufacturing Process Analysis of Pharmaceutical Cannabis
10.4 Industry Chain Structure of Pharmaceutical Cannabis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Cannabis Distributors
11.3 Pharmaceutical Cannabis Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL CANNABIS BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Cannabis Market Size Forecast by Region
12.1.1 Global Pharmaceutical Cannabis Forecast by Region (2024-2029)
12.1.2 Global Pharmaceutical Cannabis Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Cannabis Forecast by Type
12.7 Global Pharmaceutical Cannabis Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Canopy Growth Corporation
13.1.1 Canopy Growth Corporation Company Information
13.1.2 Canopy Growth Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
13.1.3 Canopy Growth Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Canopy Growth Corporation Main Business Overview
13.1.5 Canopy Growth Corporation Latest Developments
13.2 GW Pharmaceuticals, plc
13.2.1 GW Pharmaceuticals, plc Company Information
13.2.2 GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Portfolios and Specifications
13.2.3 GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GW Pharmaceuticals, plc Main Business Overview
13.2.5 GW Pharmaceuticals, plc Latest Developments
13.3 Aurora Cannabis, Inc.
13.3.1 Aurora Cannabis, Inc. Company Information
13.3.2 Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.3.3 Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aurora Cannabis, Inc. Main Business Overview
13.3.5 Aurora Cannabis, Inc. Latest Developments
13.4 Aphria, Inc.
13.4.1 Aphria, Inc. Company Information
13.4.2 Aphria, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.4.3 Aphria, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aphria, Inc. Main Business Overview
13.4.5 Aphria, Inc. Latest Developments
13.5 MedReleaf Corporation
13.5.1 MedReleaf Corporation Company Information
13.5.2 MedReleaf Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
13.5.3 MedReleaf Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MedReleaf Corporation Main Business Overview
13.5.5 MedReleaf Corporation Latest Developments
13.6 Insys Therapeutics, Inc.
13.6.1 Insys Therapeutics, Inc. Company Information
13.6.2 Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.6.3 Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Insys Therapeutics, Inc. Main Business Overview
13.6.5 Insys Therapeutics, Inc. Latest Developments
13.7 CanniMed Therapeutics, Inc.
13.7.1 CanniMed Therapeutics, Inc. Company Information
13.7.2 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.7.3 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CanniMed Therapeutics, Inc. Main Business Overview
13.7.5 CanniMed Therapeutics, Inc. Latest Developments
13.8 Cara Therapeutics, Inc.
13.8.1 Cara Therapeutics, Inc. Company Information
13.8.2 Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
13.8.3 Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cara Therapeutics, Inc. Main Business Overview
13.8.5 Cara Therapeutics, Inc. Latest Developments
13.9 United Cannabis Corporation
13.9.1 United Cannabis Corporation Company Information
13.9.2 United Cannabis Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
13.9.3 United Cannabis Corporation Pharmaceutical Cannabis Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 United Cannabis Corporation Main Business Overview
13.9.5 United Cannabis Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical Cannabis Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pharmaceutical Cannabis Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of THC-dominant
Table 4. Major Players of CBD-dominant
Table 5. Major Players of Balanced THC & CBD
Table 6. Global Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 7. Global Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Table 8. Global Pharmaceutical Cannabis Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pharmaceutical Cannabis Revenue Market Share by Type (2018-2023)
Table 10. Global Pharmaceutical Cannabis Sale Price by Type (2018-2023) & (US$/KG)
Table 11. Global Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 12. Global Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Table 13. Global Pharmaceutical Cannabis Revenue by Application (2018-2023)
Table 14. Global Pharmaceutical Cannabis Revenue Market Share by Application (2018-2023)
Table 15. Global Pharmaceutical Cannabis Sale Price by Application (2018-2023) & (US$/KG)
Table 16. Global Pharmaceutical Cannabis Sales by Company (2018-2023) & (Kiloton)
Table 17. Global Pharmaceutical Cannabis Sales Market Share by Company (2018-2023)
Table 18. Global Pharmaceutical Cannabis Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pharmaceutical Cannabis Revenue Market Share by Company (2018-2023)
Table 20. Global Pharmaceutical Cannabis Sale Price by Company (2018-2023) & (US$/KG)
Table 21. Key Manufacturers Pharmaceutical Cannabis Producing Area Distribution and Sales Area
Table 22. Players Pharmaceutical Cannabis Products Offered
Table 23. Pharmaceutical Cannabis Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pharmaceutical Cannabis Sales by Geographic Region (2018-2023) & (Kiloton)
Table 27. Global Pharmaceutical Cannabis Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pharmaceutical Cannabis Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pharmaceutical Cannabis Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pharmaceutical Cannabis Sales by Country/Region (2018-2023) & (Kiloton)
Table 31. Global Pharmaceutical Cannabis Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pharmaceutical Cannabis Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pharmaceutical Cannabis Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pharmaceutical Cannabis Sales by Country (2018-2023) & (Kiloton)
Table 35. Americas Pharmaceutical Cannabis Sales Market Share by Country (2018-2023)
Table 36. Americas Pharmaceutical Cannabis Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pharmaceutical Cannabis Revenue Market Share by Country (2018-2023)
Table 38. Americas Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 39. Americas Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 40. APAC Pharmaceutical Cannabis Sales by Region (2018-2023) & (Kiloton)
Table 41. APAC Pharmaceutical Cannabis Sales Market Share by Region (2018-2023)
Table 42. APAC Pharmaceutical Cannabis Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pharmaceutical Cannabis Revenue Market Share by Region (2018-2023)
Table 44. APAC Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 45. APAC Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 46. Europe Pharmaceutical Cannabis Sales by Country (2018-2023) & (Kiloton)
Table 47. Europe Pharmaceutical Cannabis Sales Market Share by Country (2018-2023)
Table 48. Europe Pharmaceutical Cannabis Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pharmaceutical Cannabis Revenue Market Share by Country (2018-2023)
Table 50. Europe Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 51. Europe Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Pharmaceutical Cannabis Sales by Country (2018-2023) & (Kiloton)
Table 53. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pharmaceutical Cannabis Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pharmaceutical Cannabis Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 57. Middle East & Africa Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 58. Key Market Drivers & Growth Opportunities of Pharmaceutical Cannabis
Table 59. Key Market Challenges & Risks of Pharmaceutical Cannabis
Table 60. Key Industry Trends of Pharmaceutical Cannabis
Table 61. Pharmaceutical Cannabis Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pharmaceutical Cannabis Distributors List
Table 64. Pharmaceutical Cannabis Customer List
Table 65. Global Pharmaceutical Cannabis Sales Forecast by Region (2024-2029) & (Kiloton)
Table 66. Global Pharmaceutical Cannabis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pharmaceutical Cannabis Sales Forecast by Country (2024-2029) & (Kiloton)
Table 68. Americas Pharmaceutical Cannabis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pharmaceutical Cannabis Sales Forecast by Region (2024-2029) & (Kiloton)
Table 70. APAC Pharmaceutical Cannabis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pharmaceutical Cannabis Sales Forecast by Country (2024-2029) & (Kiloton)
Table 72. Europe Pharmaceutical Cannabis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pharmaceutical Cannabis Sales Forecast by Country (2024-2029) & (Kiloton)
Table 74. Middle East & Africa Pharmaceutical Cannabis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pharmaceutical Cannabis Sales Forecast by Type (2024-2029) & (Kiloton)
Table 76. Global Pharmaceutical Cannabis Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pharmaceutical Cannabis Sales Forecast by Application (2024-2029) & (Kiloton)
Table 78. Global Pharmaceutical Cannabis Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Canopy Growth Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 80. Canopy Growth Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
Table 81. Canopy Growth Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 82. Canopy Growth Corporation Main Business
Table 83. Canopy Growth Corporation Latest Developments
Table 84. GW Pharmaceuticals, plc Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 85. GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Portfolios and Specifications
Table 86. GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 87. GW Pharmaceuticals, plc Main Business
Table 88. GW Pharmaceuticals, plc Latest Developments
Table 89. Aurora Cannabis, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 90. Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 91. Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 92. Aurora Cannabis, Inc. Main Business
Table 93. Aurora Cannabis, Inc. Latest Developments
Table 94. Aphria, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 95. Aphria, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 96. Aphria, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 97. Aphria, Inc. Main Business
Table 98. Aphria, Inc. Latest Developments
Table 99. MedReleaf Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 100. MedReleaf Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
Table 101. MedReleaf Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 102. MedReleaf Corporation Main Business
Table 103. MedReleaf Corporation Latest Developments
Table 104. Insys Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 105. Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 106. Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 107. Insys Therapeutics, Inc. Main Business
Table 108. Insys Therapeutics, Inc. Latest Developments
Table 109. CanniMed Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 110. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 111. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 112. CanniMed Therapeutics, Inc. Main Business
Table 113. CanniMed Therapeutics, Inc. Latest Developments
Table 114. Cara Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 115. Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 116. Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 117. Cara Therapeutics, Inc. Main Business
Table 118. Cara Therapeutics, Inc. Latest Developments
Table 119. United Cannabis Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 120. United Cannabis Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
Table 121. United Cannabis Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 122. United Cannabis Corporation Main Business
Table 123. United Cannabis Corporation Latest Developments
Table 1. Pharmaceutical Cannabis Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pharmaceutical Cannabis Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of THC-dominant
Table 4. Major Players of CBD-dominant
Table 5. Major Players of Balanced THC & CBD
Table 6. Global Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 7. Global Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Table 8. Global Pharmaceutical Cannabis Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pharmaceutical Cannabis Revenue Market Share by Type (2018-2023)
Table 10. Global Pharmaceutical Cannabis Sale Price by Type (2018-2023) & (US$/KG)
Table 11. Global Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 12. Global Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Table 13. Global Pharmaceutical Cannabis Revenue by Application (2018-2023)
Table 14. Global Pharmaceutical Cannabis Revenue Market Share by Application (2018-2023)
Table 15. Global Pharmaceutical Cannabis Sale Price by Application (2018-2023) & (US$/KG)
Table 16. Global Pharmaceutical Cannabis Sales by Company (2018-2023) & (Kiloton)
Table 17. Global Pharmaceutical Cannabis Sales Market Share by Company (2018-2023)
Table 18. Global Pharmaceutical Cannabis Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pharmaceutical Cannabis Revenue Market Share by Company (2018-2023)
Table 20. Global Pharmaceutical Cannabis Sale Price by Company (2018-2023) & (US$/KG)
Table 21. Key Manufacturers Pharmaceutical Cannabis Producing Area Distribution and Sales Area
Table 22. Players Pharmaceutical Cannabis Products Offered
Table 23. Pharmaceutical Cannabis Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pharmaceutical Cannabis Sales by Geographic Region (2018-2023) & (Kiloton)
Table 27. Global Pharmaceutical Cannabis Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pharmaceutical Cannabis Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pharmaceutical Cannabis Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pharmaceutical Cannabis Sales by Country/Region (2018-2023) & (Kiloton)
Table 31. Global Pharmaceutical Cannabis Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pharmaceutical Cannabis Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pharmaceutical Cannabis Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pharmaceutical Cannabis Sales by Country (2018-2023) & (Kiloton)
Table 35. Americas Pharmaceutical Cannabis Sales Market Share by Country (2018-2023)
Table 36. Americas Pharmaceutical Cannabis Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pharmaceutical Cannabis Revenue Market Share by Country (2018-2023)
Table 38. Americas Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 39. Americas Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 40. APAC Pharmaceutical Cannabis Sales by Region (2018-2023) & (Kiloton)
Table 41. APAC Pharmaceutical Cannabis Sales Market Share by Region (2018-2023)
Table 42. APAC Pharmaceutical Cannabis Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pharmaceutical Cannabis Revenue Market Share by Region (2018-2023)
Table 44. APAC Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 45. APAC Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 46. Europe Pharmaceutical Cannabis Sales by Country (2018-2023) & (Kiloton)
Table 47. Europe Pharmaceutical Cannabis Sales Market Share by Country (2018-2023)
Table 48. Europe Pharmaceutical Cannabis Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pharmaceutical Cannabis Revenue Market Share by Country (2018-2023)
Table 50. Europe Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 51. Europe Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Pharmaceutical Cannabis Sales by Country (2018-2023) & (Kiloton)
Table 53. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pharmaceutical Cannabis Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pharmaceutical Cannabis Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pharmaceutical Cannabis Sales by Type (2018-2023) & (Kiloton)
Table 57. Middle East & Africa Pharmaceutical Cannabis Sales by Application (2018-2023) & (Kiloton)
Table 58. Key Market Drivers & Growth Opportunities of Pharmaceutical Cannabis
Table 59. Key Market Challenges & Risks of Pharmaceutical Cannabis
Table 60. Key Industry Trends of Pharmaceutical Cannabis
Table 61. Pharmaceutical Cannabis Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pharmaceutical Cannabis Distributors List
Table 64. Pharmaceutical Cannabis Customer List
Table 65. Global Pharmaceutical Cannabis Sales Forecast by Region (2024-2029) & (Kiloton)
Table 66. Global Pharmaceutical Cannabis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pharmaceutical Cannabis Sales Forecast by Country (2024-2029) & (Kiloton)
Table 68. Americas Pharmaceutical Cannabis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pharmaceutical Cannabis Sales Forecast by Region (2024-2029) & (Kiloton)
Table 70. APAC Pharmaceutical Cannabis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pharmaceutical Cannabis Sales Forecast by Country (2024-2029) & (Kiloton)
Table 72. Europe Pharmaceutical Cannabis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pharmaceutical Cannabis Sales Forecast by Country (2024-2029) & (Kiloton)
Table 74. Middle East & Africa Pharmaceutical Cannabis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pharmaceutical Cannabis Sales Forecast by Type (2024-2029) & (Kiloton)
Table 76. Global Pharmaceutical Cannabis Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pharmaceutical Cannabis Sales Forecast by Application (2024-2029) & (Kiloton)
Table 78. Global Pharmaceutical Cannabis Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Canopy Growth Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 80. Canopy Growth Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
Table 81. Canopy Growth Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 82. Canopy Growth Corporation Main Business
Table 83. Canopy Growth Corporation Latest Developments
Table 84. GW Pharmaceuticals, plc Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 85. GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Portfolios and Specifications
Table 86. GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 87. GW Pharmaceuticals, plc Main Business
Table 88. GW Pharmaceuticals, plc Latest Developments
Table 89. Aurora Cannabis, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 90. Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 91. Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 92. Aurora Cannabis, Inc. Main Business
Table 93. Aurora Cannabis, Inc. Latest Developments
Table 94. Aphria, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 95. Aphria, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 96. Aphria, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 97. Aphria, Inc. Main Business
Table 98. Aphria, Inc. Latest Developments
Table 99. MedReleaf Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 100. MedReleaf Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
Table 101. MedReleaf Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 102. MedReleaf Corporation Main Business
Table 103. MedReleaf Corporation Latest Developments
Table 104. Insys Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 105. Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 106. Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 107. Insys Therapeutics, Inc. Main Business
Table 108. Insys Therapeutics, Inc. Latest Developments
Table 109. CanniMed Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 110. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 111. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 112. CanniMed Therapeutics, Inc. Main Business
Table 113. CanniMed Therapeutics, Inc. Latest Developments
Table 114. Cara Therapeutics, Inc. Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 115. Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolios and Specifications
Table 116. Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 117. Cara Therapeutics, Inc. Main Business
Table 118. Cara Therapeutics, Inc. Latest Developments
Table 119. United Cannabis Corporation Basic Information, Pharmaceutical Cannabis Manufacturing Base, Sales Area and Its Competitors
Table 120. United Cannabis Corporation Pharmaceutical Cannabis Product Portfolios and Specifications
Table 121. United Cannabis Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue ($ Million), Price (US$/KG) and Gross Margin (2018-2023)
Table 122. United Cannabis Corporation Main Business
Table 123. United Cannabis Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pharmaceutical Cannabis
Figure 2. Pharmaceutical Cannabis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Cannabis Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Pharmaceutical Cannabis Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pharmaceutical Cannabis Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of THC-dominant
Figure 10. Product Picture of CBD-dominant
Figure 11. Product Picture of Balanced THC & CBD
Figure 12. Global Pharmaceutical Cannabis Sales Market Share by Type in 2022
Figure 13. Global Pharmaceutical Cannabis Revenue Market Share by Type (2018-2023)
Figure 14. Pharmaceutical Cannabis Consumed in Cancer
Figure 15. Global Pharmaceutical Cannabis Market: Cancer (2018-2023) & (Kiloton)
Figure 16. Pharmaceutical Cannabis Consumed in Arthritis
Figure 17. Global Pharmaceutical Cannabis Market: Arthritis (2018-2023) & (Kiloton)
Figure 18. Pharmaceutical Cannabis Consumed in Migraine
Figure 19. Global Pharmaceutical Cannabis Market: Migraine (2018-2023) & (Kiloton)
Figure 20. Pharmaceutical Cannabis Consumed in Epilepsy
Figure 21. Global Pharmaceutical Cannabis Market: Epilepsy (2018-2023) & (Kiloton)
Figure 22. Pharmaceutical Cannabis Consumed in Others
Figure 23. Global Pharmaceutical Cannabis Market: Others (2018-2023) & (Kiloton)
Figure 24. Global Pharmaceutical Cannabis Sales Market Share by Application (2022)
Figure 25. Global Pharmaceutical Cannabis Revenue Market Share by Application in 2022
Figure 26. Pharmaceutical Cannabis Sales Market by Company in 2022 (Kiloton)
Figure 27. Global Pharmaceutical Cannabis Sales Market Share by Company in 2022
Figure 28. Pharmaceutical Cannabis Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Pharmaceutical Cannabis Revenue Market Share by Company in 2022
Figure 30. Global Pharmaceutical Cannabis Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Pharmaceutical Cannabis Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 33. Americas Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 34. APAC Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 35. APAC Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 36. Europe Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 37. Europe Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 39. Middle East & Africa Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 40. Americas Pharmaceutical Cannabis Sales Market Share by Country in 2022
Figure 41. Americas Pharmaceutical Cannabis Revenue Market Share by Country in 2022
Figure 42. Americas Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 43. Americas Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 44. United States Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Pharmaceutical Cannabis Sales Market Share by Region in 2022
Figure 49. APAC Pharmaceutical Cannabis Revenue Market Share by Regions in 2022
Figure 50. APAC Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 51. APAC Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 52. China Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Pharmaceutical Cannabis Sales Market Share by Country in 2022
Figure 60. Europe Pharmaceutical Cannabis Revenue Market Share by Country in 2022
Figure 61. Europe Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 62. Europe Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 63. Germany Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Pharmaceutical Cannabis Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 72. Egypt Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Pharmaceutical Cannabis in 2022
Figure 78. Manufacturing Process Analysis of Pharmaceutical Cannabis
Figure 79. Industry Chain Structure of Pharmaceutical Cannabis
Figure 80. Channels of Distribution
Figure 81. Global Pharmaceutical Cannabis Sales Market Forecast by Region (2024-2029)
Figure 82. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Pharmaceutical Cannabis Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Pharmaceutical Cannabis Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pharmaceutical Cannabis
Figure 2. Pharmaceutical Cannabis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Cannabis Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Pharmaceutical Cannabis Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pharmaceutical Cannabis Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of THC-dominant
Figure 10. Product Picture of CBD-dominant
Figure 11. Product Picture of Balanced THC & CBD
Figure 12. Global Pharmaceutical Cannabis Sales Market Share by Type in 2022
Figure 13. Global Pharmaceutical Cannabis Revenue Market Share by Type (2018-2023)
Figure 14. Pharmaceutical Cannabis Consumed in Cancer
Figure 15. Global Pharmaceutical Cannabis Market: Cancer (2018-2023) & (Kiloton)
Figure 16. Pharmaceutical Cannabis Consumed in Arthritis
Figure 17. Global Pharmaceutical Cannabis Market: Arthritis (2018-2023) & (Kiloton)
Figure 18. Pharmaceutical Cannabis Consumed in Migraine
Figure 19. Global Pharmaceutical Cannabis Market: Migraine (2018-2023) & (Kiloton)
Figure 20. Pharmaceutical Cannabis Consumed in Epilepsy
Figure 21. Global Pharmaceutical Cannabis Market: Epilepsy (2018-2023) & (Kiloton)
Figure 22. Pharmaceutical Cannabis Consumed in Others
Figure 23. Global Pharmaceutical Cannabis Market: Others (2018-2023) & (Kiloton)
Figure 24. Global Pharmaceutical Cannabis Sales Market Share by Application (2022)
Figure 25. Global Pharmaceutical Cannabis Revenue Market Share by Application in 2022
Figure 26. Pharmaceutical Cannabis Sales Market by Company in 2022 (Kiloton)
Figure 27. Global Pharmaceutical Cannabis Sales Market Share by Company in 2022
Figure 28. Pharmaceutical Cannabis Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Pharmaceutical Cannabis Revenue Market Share by Company in 2022
Figure 30. Global Pharmaceutical Cannabis Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Pharmaceutical Cannabis Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 33. Americas Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 34. APAC Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 35. APAC Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 36. Europe Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 37. Europe Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Pharmaceutical Cannabis Sales 2018-2023 (Kiloton)
Figure 39. Middle East & Africa Pharmaceutical Cannabis Revenue 2018-2023 ($ Millions)
Figure 40. Americas Pharmaceutical Cannabis Sales Market Share by Country in 2022
Figure 41. Americas Pharmaceutical Cannabis Revenue Market Share by Country in 2022
Figure 42. Americas Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 43. Americas Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 44. United States Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Pharmaceutical Cannabis Sales Market Share by Region in 2022
Figure 49. APAC Pharmaceutical Cannabis Revenue Market Share by Regions in 2022
Figure 50. APAC Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 51. APAC Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 52. China Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Pharmaceutical Cannabis Sales Market Share by Country in 2022
Figure 60. Europe Pharmaceutical Cannabis Revenue Market Share by Country in 2022
Figure 61. Europe Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 62. Europe Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 63. Germany Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Pharmaceutical Cannabis Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Pharmaceutical Cannabis Sales Market Share by Application (2018-2023)
Figure 72. Egypt Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Pharmaceutical Cannabis Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Pharmaceutical Cannabis in 2022
Figure 78. Manufacturing Process Analysis of Pharmaceutical Cannabis
Figure 79. Industry Chain Structure of Pharmaceutical Cannabis
Figure 80. Channels of Distribution
Figure 81. Global Pharmaceutical Cannabis Sales Market Forecast by Region (2024-2029)
Figure 82. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Pharmaceutical Cannabis Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Pharmaceutical Cannabis Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Application (2024-2029)
